Skip to Content

  • Search

View Additional Section Content

ECOG E1697 - Phase III Randomized Study of Four Weeks High Dose IFN-alpha2b in Stage T3-T4 or N1 (microscopic) Melanoma.

Clinical Trial Categories

  • Melanoma
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details